FdaApplication
NDA 021153
Identifiers
- fda_app_no: NDA021153
Properties
| Property | Value |
|---|---|
| applicant_name | ASTRAZENECA PHARMACEUTICALS LP |
| application_type | NDA |
| approval_date | 2001-02-20 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NEXIUM | ESOMEPRAZOLE MAGNESIUM | EQ 20MG BASE | CAPSULE, DELAYED REL PELLETS;ORAL |
| NEXIUM | ESOMEPRAZOLE MAGNESIUM | EQ 40MG BASE | CAPSULE, DELAYED REL PELLETS;ORAL |
2 products